Home LiteratureArticle Details
PMID: 15483673 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells.

Leukemia ·Vol. 18 ·No. 12 ·2004-12-00 ·Pages 1964-70

Ringshausen I, Dechow T, Schneller F, Weick K, Oelsner M, Peschel C, Decker T

Abstract

In the present work we investigated the role and biological significance of mitogen activated protein kinases (MAPK) in B-cell chronic lymphocytic leukaemia (B-CLL). The MAPK p38 was constitutively activated in B-CLL, but not in normal peripheral B cells. In addition, we demonstrated that the upstream kinases of p38, MKK3/6 were also constitutively activated in B-CLL cells. Furthermore, we determined by EMSA that the p38 MAP kinase pathway was not linked to the constitutive high expression of NF-kappaB, a critical survival factor of B-CLL cells. Recently, it has been shown that serum levels of angiogenic factors like VEGF, bFGF and MMP-9 are elevated in the serum of CLL patients and correlate with an unfavorable prognosis. We showed that the constitutive expression of MMP-9 was dependent on p38-activity and inhibition of p38 strongly downregulated MMP-9 expression. Coculture of B-CLL cells and stromal cells can protect spontaneous apoptosis of leukemic B cells. To determine the role of permanently activated p38 and MMP-9 expression, we cocultured B-CLL cells with bone marrow stromal cells. Survival of B-CLL cells on stroma was severely impaired when p38 was inhibited. Furthermore, blockade of MMP-9 activity also antagonized the antiapoptotic effect of stromal cells.

MeSH Terms
Apoptosis Bone Marrow Cells/enzymology Coculture Techniques Electrophoretic Mobility Shift Assay Enzyme Activation Enzyme Inhibitors/pharmacology Fibroblast Growth Factor 2/metabolism Gene Expression Regulation, Enzymologic Humans Leukemia, Lymphocytic, Chronic, B-Cell/enzymology,pathology MAP Kinase Kinase 3/metabolism MAP Kinase Kinase 6/metabolism Matrix Metalloproteinase 9/metabolism Matrix Metalloproteinase Inhibitors NF-kappa B/genetics,metabolism Promoter Regions, Genetic Stromal Cells/enzymology Tumor Cells, Cultured Vascular Endothelial Growth Factor A/metabolism p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors,metabolism
Chemicals
Enzyme Inhibitors Matrix Metalloproteinase Inhibitors NF-kappa B Vascular Endothelial Growth Factor A Fibroblast Growth Factor 2 p38 Mitogen-Activated Protein Kinases MAP Kinase Kinase 3 MAP Kinase Kinase 6 MAP2K3 protein, human MAP2K6 protein, human Matrix Metalloproteinase 9
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Ringshausen I
IIIrd Department of Medicine, Technical University of Munich, Munich, Germany. iringshausen@cc.ucsf.edu
Dechow T
Schneller F
Weick K
Oelsner M
Peschel C
Decker T
Article Info
Journal
Leukemia
Abbr.
Leukemia
ISSN
0887-6924
Published
2004-12-00
Pages
1964-70
Language
English
Region
England
NLM ID
8704895
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com